The key to making it as a health startup: strategize mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M
January 19, 2021 at 10:31 am
Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo)
Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics.
Founded in 2013, Bardy set out to change the way medical professionals monitor heart conditions with a non-invasive cardiac monitor patch that helps detect arrhythmia. The Carnation Ambulatory Monitor, or CAM for short, is designed to be worn comfortably for approximately a week, with the goal of improving patient compliance. It uses a unique circuit design and algorithms to process P-wave recording. Bardy claims that its device captures clearer and more accurate heart rhythms than competing electrocardiography (ECG) monitors.
by Chantal Allam, NCBiotech writer December 17, 2020 .
DURHAM – Baebies is winning kudos for its pediatric testing platform that uses one drop of blood to perform quick tests for multiple diseases.
This week, the Durham-based biotech startup received the AACC Disruptive Technology Award at the 2020 American Association for Clinical Chemistry’s annual scientific meeting and clinical lab expo.
During the virtual competition, Baebies presented its platform called FINDER.
It features a “toaster-sized instrument and disposable cartridge,” and is powered by digital microfluidics technology, a method to manipulate separate droplets of liquid by electrical control of surface tension, or electrowetting, to perform bioassay protocols.
Durham’s Baebies Wins Accolades for its ‘Disruptive’ Screening Test
Baebies is winning kudos for its pediatric testing platform that uses one drop of blood to perform quick tests for multiple diseases.
This week, the Durham-based biotech startup received the AACC Disruptive Technology Award at the 2020 American Association for Clinical Chemistry’s annual scientific meeting and clinical lab expo.
During the virtual competition, Baebies presented its platform called FINDER.
It features a “toaster-sized instrument and disposable cartridge,” and is powered by digital microfluidics technology, a method to manipulate separate droplets of liquid by electrical control of surface tension, or electrowetting, to perform bioassay protocols.